Literature DB >> 12948430

Hypertension and obstructive sleep apnea.

Bradley G Phillips1, Virend K Somers.   

Abstract

Obstructive sleep apnea is a common disorder that is often unrecognized and underappreciated. Emerging evidence suggests that there is a causal link between obstructive sleep apnea and hypertension. This relationship appears to be independent of other comorbidities that have been previously linked to hypertension, such as obesity. The majority of studies support the contention that alleviation of sleep disordered breathing has a clinically significant beneficial impact on decreasing both nighttime and daytime blood pressure. A pathophysiologic basis for patients with sleep apnea having an increased risk for hypertension is not fully elucidated. However, there is consistent evidence that autonomic mechanisms are implicated. Sympathetic activation along with humoral responses to repetitive episodes of hypoxemia and apnea over the longer term may cause vasoconstriction, endothelial dysfunction, and possibly hypertension. Patients with sleep apnea are often obese and may be predisposed to weight gain. Hence, obesity may further contribute to hypertension in this patient population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948430     DOI: 10.1007/s11906-003-0083-0

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  45 in total

1.  Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model.

Authors:  D Brooks; R L Horner; L F Kozar; C L Render-Teixeira; E A Phillipson
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

2.  High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.

Authors:  A G Logan; S M Perlikowski; A Mente; A Tisler; R Tkacova; M Niroumand; R S Leung; T D Bradley
Journal:  J Hypertens       Date:  2001-12       Impact factor: 4.844

3.  Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea.

Authors:  B G Phillips; M Kato; K Narkiewicz; I Choe; V K Somers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-07       Impact factor: 4.733

4.  Chronic leptin infusion increases arterial pressure.

Authors:  E W Shek; M W Brands; J E Hall
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

5.  Association of hypertension and sleep-disordered breathing.

Authors:  E O Bixler; A N Vgontzas; H M Lin; T Ten Have; B E Leiby; A Vela-Bueno; A Kales
Journal:  Arch Intern Med       Date:  2000 Aug 14-28

6.  Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome.

Authors:  J F Faccenda; T W Mackay; N A Boon; N J Douglas
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

7.  Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares.

Authors:  C E Sullivan; F G Issa; M Berthon-Jones; L Eves
Journal:  Lancet       Date:  1981-04-18       Impact factor: 79.321

8.  Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea.

Authors:  I Wilcox; R R Grunstein; J A Hedner; J Doyle; F L Collins; P J Fletcher; D T Kelly; C E Sullivan
Journal:  Sleep       Date:  1993-09       Impact factor: 5.849

9.  The occurrence of sleep-disordered breathing among middle-aged adults.

Authors:  T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

10.  Sympathetic neural mechanisms in obstructive sleep apnea.

Authors:  V K Somers; M E Dyken; M P Clary; F M Abboud
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

View more
  7 in total

Review 1.  Neurogenic mechanisms underlying the rapid onset of sympathetic responses to intermittent hypoxia.

Authors:  Steve Mifflin; J Thomas Cunningham; Glenn M Toney
Journal:  J Appl Physiol (1985)       Date:  2015-05-21

2.  Role of angiotensin-converting enzyme 1 within the median preoptic nucleus following chronic intermittent hypoxia.

Authors:  Katelynn Faulk; Brent Shell; T Prashant Nedungadi; J Thomas Cunningham
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-12-21       Impact factor: 3.619

3.  Gene expression and phenotypic characterization of mouse heart after chronic constant or intermittent hypoxia.

Authors:  Chenhao Fan; Dumitru A Iacobas; Dan Zhou; Qiaofang Chen; James K Lai; Orit Gavrialov; Gabriel G Haddad
Journal:  Physiol Genomics       Date:  2005-05-31       Impact factor: 3.107

4.  Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study.

Authors:  Mohammed A Alzoghaibi; Ahmed S O Bahammam
Journal:  Sleep Breath       Date:  2005-09       Impact factor: 2.816

Review 5.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

6.  Eucapnic intermittent hypoxia augments endothelin-1 vasoconstriction in rats: role of PKCdelta.

Authors:  Kyan J Allahdadi; Laura C Duling; Benjimen R Walker; Nancy L Kanagy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-12-14       Impact factor: 4.733

7.  Inducers of post-apneic blood pressure fluctuation monitored by pulse transfer time measurement in obstructive sleep apnea varied with syndrome severity.

Authors:  Jing Xu; Ning Ding; Liang Chen; Yi Zhang; Mao Huang; Yanli Wang; Zili Meng; Xilong Zhang
Journal:  Sleep Breath       Date:  2019-01-12       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.